DD280320A5 - Herstellung von zwischenprodukten der oxophthalazinyl-essigsaeuren mit benzothiazol oder anderen heterocyclischen seitenketten - Google Patents

Herstellung von zwischenprodukten der oxophthalazinyl-essigsaeuren mit benzothiazol oder anderen heterocyclischen seitenketten Download PDF

Info

Publication number
DD280320A5
DD280320A5 DD88326849A DD32684988A DD280320A5 DD 280320 A5 DD280320 A5 DD 280320A5 DD 88326849 A DD88326849 A DD 88326849A DD 32684988 A DD32684988 A DD 32684988A DD 280320 A5 DD280320 A5 DD 280320A5
Authority
DD
German Democratic Republic
Prior art keywords
compound
formula
oxo
phthalazin
alkyl
Prior art date
Application number
DD88326849A
Other languages
German (de)
English (en)
Inventor
Banavara L Mylari
William J Zembrowski
Original Assignee
������@���Kk��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ������@���Kk�� filed Critical ������@���Kk��
Publication of DD280320A5 publication Critical patent/DD280320A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30Phthalazines
    • C07D237/32Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/89Benzo [c] furans; Hydrogenated benzo [c] furans with two oxygen atoms directly attached in positions 1 and 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
DD88326849A 1987-06-09 1988-06-07 Herstellung von zwischenprodukten der oxophthalazinyl-essigsaeuren mit benzothiazol oder anderen heterocyclischen seitenketten DD280320A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5989987A 1987-06-09 1987-06-09

Publications (1)

Publication Number Publication Date
DD280320A5 true DD280320A5 (de) 1990-07-04

Family

ID=22026001

Family Applications (3)

Application Number Title Priority Date Filing Date
DD88316492A DD281600A5 (de) 1987-06-09 1988-06-07 Herstellung von oxophthalazinyl-essigsaeuren mit benzothiazol- oder anderen heterocyclischen seitenketten
DD88326850A DD280323A5 (de) 1987-06-09 1988-06-07 Herstellung von zwischenprodukten der oxophthalazinyl-essigsaeuren mit benzothiazol- oder anderen heterocyclischen seitenketten
DD88326849A DD280320A5 (de) 1987-06-09 1988-06-07 Herstellung von zwischenprodukten der oxophthalazinyl-essigsaeuren mit benzothiazol oder anderen heterocyclischen seitenketten

Family Applications Before (2)

Application Number Title Priority Date Filing Date
DD88316492A DD281600A5 (de) 1987-06-09 1988-06-07 Herstellung von oxophthalazinyl-essigsaeuren mit benzothiazol- oder anderen heterocyclischen seitenketten
DD88326850A DD280323A5 (de) 1987-06-09 1988-06-07 Herstellung von zwischenprodukten der oxophthalazinyl-essigsaeuren mit benzothiazol- oder anderen heterocyclischen seitenketten

Country Status (26)

Country Link
EP (1) EP0295051B1 (zh)
JP (1) JPH0676391B2 (zh)
KR (1) KR900004698B1 (zh)
CN (1) CN1024347C (zh)
AT (1) ATE90347T1 (zh)
AU (1) AU593742B2 (zh)
CA (1) CA1321791C (zh)
CS (1) CS274628B2 (zh)
DD (3) DD281600A5 (zh)
DE (1) DE3881583T2 (zh)
DK (1) DK309988A (zh)
EG (1) EG18613A (zh)
ES (1) ES2040853T3 (zh)
FI (1) FI93835C (zh)
HU (1) HU205108B (zh)
IE (1) IE61499B1 (zh)
IL (1) IL86660A0 (zh)
MY (1) MY103573A (zh)
NO (1) NO176317C (zh)
NZ (1) NZ224937A (zh)
PH (1) PH25928A (zh)
PL (1) PL157690B1 (zh)
PT (1) PT87669B (zh)
SU (1) SU1678208A3 (zh)
YU (1) YU46696B (zh)
ZA (1) ZA884075B (zh)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0322153A3 (en) * 1987-12-21 1990-08-16 Pfizer Inc. Heterocyclic oxophtalazinyl acetic acids
WO1989006651A1 (en) * 1988-01-19 1989-07-27 Pfizer Inc. 1h-indazole-3-acetic acids as aldose reductase inhibitors
US4904782A (en) * 1988-02-29 1990-02-27 Pfizer Inc. Process for the production of phthalazineacetic acid ester derivatives and a novel intermediate
US4954629A (en) * 1989-05-11 1990-09-04 Pfizer Inc. Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof
FR2647676A1 (fr) * 1989-06-05 1990-12-07 Union Pharma Scient Appl Nouveaux derives de pyridazinone, leurs procedes de preparation, medicaments les contenant, utiles notamment comme inhibiteurs de l'aldose reductase
WO1991009019A1 (en) * 1989-12-15 1991-06-27 Pfizer Inc. Substituted oxophthalazinyl acetic acids and analogs thereof
US5064830A (en) * 1990-08-02 1991-11-12 Pfizer Inc. Lowering of blood uric acid levels
WO1992003432A1 (en) * 1990-08-28 1992-03-05 Pfizer Inc. 3-(5-trifluoromethylbenzothiazol-2-ylmethyl)-4-oxo-3h-phythalazin-1-ylacetic acid monohydrate
AU658887B2 (en) * 1991-03-28 1995-05-04 Pfizer Inc. Pyridazinone acetic acids as aldose reductase inhibitors
FR2682108B1 (fr) * 1991-10-07 1994-01-07 Lipha Acide 3,4-dihydro-4-oxo-3(prop-2-enyl)-1-phtalazineacetiques et derives, leurs preparations et medicaments les contenant.
EP0652213B1 (en) * 1993-10-06 1997-08-27 SUMIKA FINE CHEMICALS Co., Ltd. Method for producing alkyl 3-phthalidylideneacetate
US5700819A (en) * 1994-11-29 1997-12-23 Grelan Pharmaceutical Co., Ltd. 2-substituted benzothiazole derivatives and prophylactic and therapeutic agents for the treatment of diabetic complications
IL124236A (en) * 1997-05-05 2003-01-12 Pfizer Pharmaceutical composition for treating or reversing diabetic cardiomyopathy comprising aldose reductase inhibitor
EP0982306A3 (en) * 1998-08-21 2000-07-05 Pfizer Products Inc. Polymorph of zopolrestat monohydrate
SG82702A1 (en) * 1999-09-28 2001-08-21 Ebauchesfabrik Eta Ag Timepiece including a movement mounted in a casing ring
CN116970317B (zh) * 2023-03-20 2024-06-25 安徽庆丰涂料科技有限公司 可呼吸的负离子抗菌涂料及其加工工艺

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE47592B1 (en) * 1977-12-29 1984-05-02 Ici Ltd Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture
JPS5931509B2 (ja) * 1979-06-06 1984-08-02 昭和電工株式会社 3−ヒドロキシ−3−メチルフタリド又はその核置換体の製造法
IL80475A (en) * 1985-11-07 1993-01-31 Pfizer Heterocyclic-substituted 4-oxo (or thio)-3h- phthalazinyl-acetic acid derivatives and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
YU111188A (en) 1989-12-31
KR900004698B1 (ko) 1990-07-02
CS392488A2 (en) 1990-08-14
IE61499B1 (en) 1994-11-02
EG18613A (en) 1993-08-30
FI882722A0 (fi) 1988-06-08
IL86660A0 (en) 1988-11-30
IE881716L (en) 1988-12-09
FI93835B (fi) 1995-02-28
ES2040853T3 (es) 1993-11-01
ZA884075B (en) 1990-02-28
PH25928A (en) 1991-12-19
FI882722A (fi) 1988-12-10
FI93835C (fi) 1995-06-12
CS274628B2 (en) 1991-09-15
PT87669A (pt) 1988-07-01
EP0295051A2 (en) 1988-12-14
DK309988D0 (da) 1988-06-08
KR890000476A (ko) 1989-03-14
NO882516D0 (no) 1988-06-08
NO176317B (no) 1994-12-05
CN88103507A (zh) 1988-12-28
AU593742B2 (en) 1990-02-15
DE3881583D1 (de) 1993-07-15
AU1749188A (en) 1988-12-15
PT87669B (pt) 1992-09-30
NZ224937A (en) 1991-01-29
JPS643173A (en) 1989-01-06
YU46696B (sh) 1994-04-05
HU205108B (en) 1992-03-30
DK309988A (da) 1988-12-10
MY103573A (en) 1993-08-28
JPH0676391B2 (ja) 1994-09-28
SU1678208A3 (ru) 1991-09-15
NO882516L (no) 1988-12-12
ATE90347T1 (de) 1993-06-15
DE3881583T2 (de) 1993-09-16
NO176317C (no) 1995-03-15
PL272899A1 (en) 1989-07-10
PL157690B1 (en) 1992-06-30
DD281600A5 (de) 1990-08-15
EP0295051B1 (en) 1993-06-09
DD280323A5 (de) 1990-07-04
EP0295051A3 (en) 1989-03-22
CA1321791C (en) 1993-08-31
CN1024347C (zh) 1994-04-27

Similar Documents

Publication Publication Date Title
DE69723846T2 (de) Verfahren zur Herstellung von Sildenafil
DD280320A5 (de) Herstellung von zwischenprodukten der oxophthalazinyl-essigsaeuren mit benzothiazol oder anderen heterocyclischen seitenketten
EP0039844A2 (de) Verfahren zur Herstellung von O-substituierten Derivaten des (+)-Cyanidan-3-ols
EP0606065B1 (de) Verfahren zur Herstellung von Biphenylderivaten
EP0380712B1 (de) Verfahren zur Herstellung von 2,6-Dichlordiphenylaminessigsäurederivaten
DE2841644C2 (zh)
DE2320040A1 (de) Verfahren zur herstellung von 7acylamino-desacetoxy-cephalosporansaeureester
EP0505742A2 (de) Verfahren zur Herstellung von in 3-Stellung substituierten 4-Cyano-pyrrolverbindungen
EP0454623B1 (de) Verfahren zur Herstellung von linearen 1,3-Diketonen
EP0299277B1 (de) Verfahren zur Herstellung von substituierten Pyridylalkylketonen
DE2624344C2 (de) Verfahren zur Herstellung von in 1-Stellung unsubstituierten 3-(2-Hydroxyäthyl)-indol-Derivaten
DE69013726T2 (de) Verbessertes Verfahren für die Herstellung von o-Carboxypyridyl- und o-Carboxychinolylimidazolinonen.
CH638516A5 (en) Process for preparing substituted aminoquinazoline derivatives
DE4426373A1 (de) 3-Substituierte Chinolin-5-carbonsäurederivate und Verfahren zu ihrer Herstellung
EP0302227B1 (de) 5-Halogen-6-amino-nikotin-säurehalogenide, ihre Herstellung und ihre Verwendung
EP0090769B1 (de) Verfahren zur Herstellung von 1,2,5,6-Tetrahydro-4H-pyrrolo(3,2,1-ij)-chinolin-4-on und neue 5-Halogen-1,2,3-(1,2-dihydropyrrolo)-4-chinolone als Zwischenprodukte zur Durchführung des Verfahrens
DE2804894A1 (de) Halogen-benzofuranon-carbonsaeuren
CH632487A5 (en) Process for preparing novel cyanoacetanilide derivatives
EP0341478A2 (de) Verfahren zur Herstellung von 2,3-Dichlor-5-acetylpyridin
DE2462459C3 (de) 5-Halogen-pyrazo!-4-carboxa!dehyde und Verfahren zu ihrer Herstellung
DE2406972B2 (de) Verfahren zur Herstellung von 5-Sulfamoylanthranilsäuren
DE69711397T2 (de) Herstellung von einem hydrazon-beta-ketoester durch reaktion mit einem diazoester
DE2619321C2 (de) Oxalsäurederivate, ihre Herstellung und ihre Verwendung
DE69127396T2 (de) Verfahren zur Herstellung von Dihydrofuranonderivaten
AT367394B (de) Verfahren zur herstellung neuer indanderivate

Legal Events

Date Code Title Description
NPV Change in the person, the name or the address of the representative (addendum to changes before extension act)
ENJ Ceased due to non-payment of renewal fee